Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution.


Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
05 07 2021
Historique:
pubmed: 29 5 2021
medline: 11 1 2022
entrez: 28 5 2021
Statut: ppublish

Résumé

The biodistribution of molecular imaging probes or tracers mainly depends on the chemical nature of the probe and the preferred metabolization and excretion routes. Small molecules have rather short half-lives while antibodies reside inside the organism for a longer period of time. An excretion via kidneys and bladder is faster than a mainly hepatobiliary elimination. To manipulate the biodistribution behavior of probes, different strategies have been pursued, including utilizing serum albumin as an inherent transport mechanism for small molecules. Here, we modified an existing small molecular fluorescent probe targeted to the endothelin-A receptor (ET

Identifiants

pubmed: 34048242
doi: 10.1021/acs.molpharmaceut.1c00064
doi:

Substances chimiques

Fluorescent Dyes 0
Molecular Probes 0
Receptor, Endothelin A 0
Serum Albumin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2574-2585

Auteurs

Carsten Höltke (C)

Clinic for Radiology, University Hospital Münster, 48149 Münster, Germany.

Martin Grewer (M)

Clinic for Radiology, University Hospital Münster, 48149 Münster, Germany.

Miriam Stölting (M)

Clinic for Radiology, University Hospital Münster, 48149 Münster, Germany.

Christiane Geyer (C)

Clinic for Radiology, University Hospital Münster, 48149 Münster, Germany.

Moritz Wildgruber (M)

Clinic for Radiology, University Hospital Münster, 48149 Münster, Germany.
Department of Radiology, University Hospital, LMU Munich, 80539 Munich, Germany.

Anne Helfen (A)

Clinic for Radiology, University Hospital Münster, 48149 Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH